Lessons from the Trajectory of Innovation

2013
Giovanni Colella, Nina Nashif, Michael Weintraub, Juan Enriquez and Josh Stein

Giovanni Colella

SPECIAL SESSION: INNOVATION IN FOCUS
Shifting the Curve from Start to Scale to Exit: Lessons from the Trajectory of Innovation
Discussion Group

Giovanni Colella co-founded Castlight Health in 2008, along with Todd Park (currently U.S. chief technology officer and formerly the CTO of the U.S. Department of Health and Human Services) and Bryan Roberts of Venrock.

Prior to co-founding Castlight, Giovanni was Founder, President and CEO of RelayHealth, which was acquired by McKesson. Giovanni graduated with an M.D. from the Universita Degli Studi di Milano in Italy and earned his M.B.A. from Columbia Business School.

Nina Nashif

SPECIAL SESSION: INNOVATION IN FOCUS
Shifting the Curve from Start to Scale to Exit: Lessons from the Trajectory of Innovation
Discussion Group

Nina Nashif is Founder and CEO of Healthbox, a business accelerator created to support early-stage entrepreneurs and stimulate innovation in the healthcare industry.

Nina is best known for her expertise in creating entrepreneurial ventures and leading high performing teams to achieve results. Her background includes more than ten years of global business experience within very different organizational settings. 

Nina has been recognized by the World Economic Forum as a Young Global Leader and by Crain’s Chicago Business as a 40 Under 40. 

Michael Weintraub

SPECIAL SESSION: INNOVATION IN FOCUS
Shifting the Curve from Start to Scale to Exit: Lessons from the Trajectory of Innovation
Discussion Group

Michael is Founder and CEO of Humedica, recently acquired by UnitedHealth Group. Previously, he was CEO of PharMetrics, which was sold to IMS Health in 2005. Michael has 30 years of experience in healthcare information technology. He is Founding Chairman of Phreesia, and sits on the Board of the medical informatics subsidiary of the American Medical Group Association (AMGA).  Michael is on the Board of JDRF New England Chapter. He received his MBA from Harvard Business School and his BA in Economics from Brandeis University.

Juan Enriquez

SPECIAL SESSION: INNOVATION IN FOCUS
Shifting the Curve from Start to Scale to Exit: Lessons from the Trajectory of Innovation
Moderator

Mr. Enriquez is an experienced business leader, author, and academic who is recognized as one of the world’s leading authorities on the economic and political impacts of life sciences. He is a Managing Director in Excel Venture Management, a venture capital firm that invests in companies that apply transformative life science technologies to solve problems in healthcare and beyond.

He was the founding director of Harvard Business School’s Life Sciences Project. He then founded Biotechonomy LLC, a life sciences research and investment firm, where he remains as Chairman and CEO. In July of 2005, he co-founded Synthetic Genomics, Inc., a synthetic biology company focused on developing and commercializing genomic-driven solutions to address global energy, medicine, clean water, and food challenges. He has been an active investor in early-stage private companies in the biotechnology and information sciences sectors. While at Harvard, he wrote various articles and case studies, won a McKinsey Prize, and published the best-selling As the Future Catches You, an analysis of the impact of genomics on business and society. His most recent publication is an eBook co-authored with Dr. Steve Gullans, Homo Evolutis: A Short Tour of our New Species, which describes a world where humans increasingly shape their environment, themselves, and other species. Mr. Enriquez serves on a number of boards including Cabot Corporation, Synthetic Genomics, Catch.com, Shape Up, the Public Interfaces Steering Committee of the Division of Earth & Life Sciences of the National Academy of Sciences, The Genetics Advisory Council of Harvard Medical School, The Chairman’s International Council of the America’s Society, and the Visiting Committee of Harvard’s David Rockefeller Center.

He earned a BA and MBA from Harvard, with Honors.

Josh Stein

SPECIAL SESSION: INNOVATION IN FOCUS
Shifting the Curve from Start to Scale to Exit: Lessons from the Trajectory of Innovation 
Discussion Group


BIO:
Josh is passionate about creating value in this world by alleviating the problem of medication adherence.

He received his MBA from Wharton in 2012, with majors in Entrepreneurial Mgmt and Marketing & Operations Mgmt. Before that, he worked for a number of successful startups in NYC such as Lot18, PlaceVine, and FreshDirect.

In 2006, he graduated from Wash U. in St. Louis, with majors in Economics and Finance. Oh, and he performs stand-up comedy.

Share

(?)
120

Tags

Keywords